Results 191 to 200 of about 2,612,675 (336)

Multiphysics Simulation for Efficient and Reliable Systems for Low-Temperature Plasma Treatment of Metals. [PDF]

Materials (Basel)
Penkova NY, Varhoshkov BE, Todorov V, Antchev H, Krumov K, Iliev V.   +5 more
europepmc   +1 more source

Metamaterials formed on the surface of silicon carbide by plasma treatment

V S Klimin, A. V. Dem′yanenko, Ivan N. Bobkov   +2 more
openalex   +1 more source

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin, Liu Dong, Ying Wang, Dingxian He, Chong Yan, Jianying Xi, Haoqin Jiang, Yu Shi, Ming Guan, Chongbo Zhao, Jie Song, Sushan Luo   +11 more
wiley   +1 more source

Plasma Treatment - Results of Skin Microbiome Analysis. [PDF]

Clin Cosmet Investig Dermatol
Watanabe C.
europepmc   +1 more source

Trioxsalen bath plus UVA treatment of psoriasis. Plasma concentration of the drug and clinical results

, 1981
Salo Op, A Lassus, J. Taskinen
openalex   +2 more sources

Comparison of hematological and biochemical parameters in COVID-19 pneumonia patients before and after convalescent plasma (CP) treatment

, 2022
Esra Polat, Fatma Yekta URKMEZ
openalex   +2 more sources

Remote Monitoring in Myasthenia Gravis: Exploring Symptom Variability

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is a rare, autoimmune disorder characterized by fluctuating muscle weakness and potential life‐threatening crises. While continuous specialized care is essential, access barriers often delay timely interventions. To address this, we developed MyaLink, a telemedical platform for MG patients.
Maike Stein, Maximilian Mönch, Meret Herdick, Frauke Stascheit, Sarah Hoffmann, Hannah Preßler, Philipp Mergenthaler, Carla Dusemund, Paolo Doksani, Haoqi Sun, Pushpa Narayanaswami, Andreas Meisel, Lea Gerischer, Sophie Lehnerer   +13 more
wiley   +1 more source

Plasma treatment of ZnO tetrapod-BiOBr heterojunction supported on PET waste for photocatalytic degradation of oil in water. [PDF]

Sci Rep
Nourabi F, Allahyari S, Rahemi N, Mishra YK.   +3 more
europepmc   +1 more source

Plasma treatment of rice husk ash for application in tire retread compounds based on natural rubber [PDF]

Suélen Moresco, Mariusz Siciński, Tomasz Gozdek, Marcelo Giovanela, Larissa N. Carli, Janaína da Silva Crespo, Dariusz M. Bieliński   +6 more
openalex   +1 more source

Real‐World Performance of CSF Kappa Free Light Chains in the 2024 McDonald Criteria

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Kappa free light chains (KFLCs) in the cerebrospinal fluid (CSF) have a similar performance to CSF‐restricted oligoclonal bands (OCB) for multiple sclerosis (MS) diagnosis. To help with implementation, we set out to resolve several remaining uncertainties: (1) performance in a real‐world cohort and the 2024 McDonald criteria; (2 ...
Maya M. Leibowitz, Ryan Cooper, Stefania Kaninia, Kathryn I. Challis, Will Greenway, Maria Bonello, Mahmoud Elbahnasawi, Deborah T. Shode, Dominika Gajdasik, Victor Iliev, Alison M. E. Whitelegg, Ian Galea   +11 more
wiley   +1 more source